Modeling osteosarcoma to identify novel therapeutic targets.
|
Stanford University / Julien Sage |
Young Investigator Grants |
2006 |
California |
Characterization of Pre-Leukemia Associated with Familial RUNX1 Mutations |
Stanford University / Ravi Majeti, MD/PhD |
RARE Grant Program (Research Accelerating RUNX1 Exploration) |
2016 |
California |
A Pilot Study of the Feasibility and Acceptability of an Interactive Computerized Symptom Assessment Tool to Assess Disease and Treatment-Related Symptoms Experienced by Children with Cancer |
University of California San Francisco / Tina Baggott, RN, PhD, PNP |
Nurse Researcher Grants |
2009 |
California |
Single Cell Analysis of Leukemia Initiation |
Stanford University / Michael Cleary, MD |
Innovation Grants |
2015 |
California |
Predicting Outcome for Patients with Metastatic Neuroblastoma by Analysis of Bone Marrow and Blood for a Neuroblastoma Gene Expression Signature |
Children’s Hospital Los Angeles / Robert Seeger |
Innovation Grants |
2010 |
California |
Identification of Aberrantly Methylated Differentially Expressed Genes to Distinguish High- vs. Low-Risk Retinoblastoma |
Children’s Hospital Los Angeles / Jesse Berry, MD |
Reach Grants |
2023 |
California |
New Approaches to Neuroblastoma Therapy (NANT) Consortium
|
Children’s Hospital Los Angeles / Robert Seeger, MD |
Phase I/II Infrastructure Grants |
2006 |
California |
Enhancing Effectiveness of Immune Checkpoint Therapy in Neuroblastoma |
Children’s Hospital Los Angeles / Shahab Asgharzadeh, MD |
Innovation Grants |
2015 |
California |
Saturating CRISPR gene body scans in MLL-rearranged leukemia |
Beckman Research Institute of City of Hope / Chun-Wei Chen, PhD |
Innovation Grants |
2019 |
California |
Adoptive Immunotherapy of Tr1 Cells to Improve Outcome of Allo-HSCT Treatment for Pediatric AML |
Stanford University / Maria-Grazia Roncarolo, MD & Rosa Bachetta, MD |
Reach Grants |
2015 |
California |